Hopman Mark

Chief Commercial OfficerBeta Bionics, Inc. (BBNX) · full profile →Form 4 · filed Sep 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$371K
Net Open-Market Flow
-$371K
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 5, 2025Sell(S)11K$20.56$235K31K
Sep 5, 2025Option exercise(M)11K$5.10$58K43K
Sep 4, 2025Sell(S)7K$19.97$136K31K
Sep 4, 2025Option exercise(M)4K$5.10$21K38K
Sep 4, 2025Option exercise(M)656$5.10$3K34K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 5, 2025Option exercise(M)11K$022K
Sep 4, 2025Option exercise(M)656$066K
Sep 4, 2025Option exercise(M)4K$033K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-023899) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.